Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 2
1980 4
1981 4
1982 8
1983 2
1984 7
1985 2
1986 9
1987 17
1988 16
1989 12
1990 12
1991 17
1992 17
1993 32
1994 23
1995 41
1996 41
1997 40
1998 53
1999 49
2000 66
2001 71
2002 88
2003 99
2004 128
2005 186
2006 188
2007 209
2008 278
2009 347
2010 405
2011 458
2012 541
2013 569
2014 611
2015 629
2016 674
2017 738
2018 872
2019 937
2020 1084
2021 1211
2022 1437
2023 1366
2024 1243
2025 2

Text availability

Article attribute

Article type

Publication date

Search Results

13,366 results

Results by year

Filters applied: . Clear all
Page 1
Targeting cancer stem cell pathways for cancer therapy.
Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H. Yang L, et al. Among authors: zhao g. Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5. Signal Transduct Target Ther. 2020. PMID: 32296030 Free PMC article. Review.
The mitophagy pathway and its implications in human diseases.
Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, Zeng Y, Cai J, Zhang DW, Zhao G. Wang S, et al. Among authors: zhao g. Signal Transduct Target Ther. 2023 Aug 16;8(1):304. doi: 10.1038/s41392-023-01503-7. Signal Transduct Target Ther. 2023. PMID: 37582956 Free PMC article. Review.
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.
Luo Y, Xia Y, Liu D, Li X, Li H, Liu J, Zhou D, Dong Y, Li X, Qian Y, Xu C, Tao K, Li G, Pan W, Zhong Q, Liu X, Xu S, Wang Z, Liu R, Zhang W, Shan W, Fang T, Wang S, Peng Z, Jin P, Jin N, Shi S, Chen Y, Wang M, Jiao X, Luo M, Gong W, Wang Y, Yao Y, Zhao Y, Huang X, Ji X, He Z, Zhao G, Liu R, Wu M, Chen G, Hong L; COCPO Consortium; Ma D, Fang Y, Liang H, Gao Q. Luo Y, et al. Among authors: zhao g. Cell. 2024 Sep 5;187(18):4905-4925.e24. doi: 10.1016/j.cell.2024.06.013. Epub 2024 Jul 5. Cell. 2024. PMID: 38971151 Free article. Clinical Trial.
Base editing of the mutated TERT promoter inhibits liver tumor growth.
Zhao G, Ma Q, Yang H, Jiang H, Xu Q, Luo S, Meng Z, Liu J, Zhu L, Lin Q, Li M, Fang J, Ma L, Qiu W, Mao Z, Lu Z. Zhao G, et al. Hepatology. 2024 Jun 1;79(6):1310-1323. doi: 10.1097/HEP.0000000000000700. Epub 2023 Nov 28. Hepatology. 2024. PMID: 38016019
Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial.
Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, Du X, Huang H, Hu J, Li G, Yu P, Li Y, Suo J, Zhao N, Zhang W, Li H, He H, Sun Y; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Liu F, et al. Among authors: zhao g. JAMA Oncol. 2020 Oct 1;6(10):1590-1597. doi: 10.1001/jamaoncol.2020.3152. JAMA Oncol. 2020. PMID: 32815991 Free PMC article. Clinical Trial.
13,366 results
You have reached the last available page of results. Please see the User Guide for more information.